Natural Product (NP) Details
| General Information of the NP (ID: NP2740) | |||||
|---|---|---|---|---|---|
| Name |
Borneol
|
||||
| Synonyms |
isoborneol; (+)-borneol
Click to Show/Hide
|
||||
| Species Origin | Chrysanthemum x morifolium ... | Click to Show/Hide | |||
| Chrysanthemum x morifolium | |||||
| Valeriana jatamansi | |||||
| Liquidambar formosana | |||||
| Alpinia zerumbet | |||||
| Baeckea frutescens | |||||
| Annona squamosa | |||||
| Abutilon indicum | |||||
| Prunus triloba | |||||
| Disease | Asthma [ICD-11: CA23] | Investigative | [1] | ||
| Structure |
|
Click to Download Mol2D MOL |
|||
| ADMET Property |
Absporption
Caco-2 Permeability
-4.637
MDCK Permeability
-4.498
PAMPA
+
HIA
- -
Distribution
VDss
0.318
PPB
52.8%
BBB
- - -
Metabolism
CYP1A2 inhibitor
- - -
CYP1A2 substrate
- - -
CYP2C19 inhibitor
- - -
CYP2C19 substrate
+
CYP2C9 inhibitor
- - -
CYP2C9 substrate
- -
CYP2D6 inhibitor
-
CYP2D6 substrate
-
CYP3A4 inhibitor
- - -
CYP3A4 substrate
+
CYP2B6 inhibitor
- - -
CYP2B6 substrate
- - -
CYP2C8 inhibitor
+++
HLM Stability
- - -
Excretion
CLplasma
14.322
T1/2
1.73
Toxicity
DILI
- -
Rat Oral Acute Toxicity
-
FDAMDD
-
Respiratory
-
Human Hepatotoxicity
+
Ototoxicity
-
Drug-induced Nephrotoxicity
-
Drug-induced Neurotoxicity
- -
Hematotoxicity
- -
Genotoxicity
- -
Tips: 1. For the classification endpoints, the prediction probability values are transformed into six symbols: 0-0.1 (- - -), 0.1-0.3 (- -), 0.3-0.5 (-), 0.5-0.7 (+), 0.7-0.9 (++), and 0.9-1.0 (+++).
2. Additionally, the corresponding relationships of the three labels are as follows: excellent; medium; poor.
Click to Show/Hide
|
||||
| Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product | |||||
| Formula |
C10H18O
|
||||
| PubChem CID | |||||
| Canonical SMILES |
CC1(C2CCC1(C(C2)O)C)C
|
||||
| InChI |
1S/C10H18O/c1-9(2)7-4-5-10(9,3)8(11)6-7/h7-8,11H,4-6H2,1-3H3
|
||||
| InChIKey |
DTGKSKDOIYIVQL-UHFFFAOYSA-N
|
||||
| CAS Number |
CAS 507-70-0
|
||||
| Herb ID | |||||
| ETMC ID | |||||
| SymMap ID | |||||
| TTD Drug ID | |||||
| Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
|---|---|---|---|---|---|---|
| α. A List of Drug(s) Whose Efficacy can be Enhanced by This NP | ||||||
| Temozolomide | Brain cancer | Click to Show/Hide the Molecular Data of This Drug | ||||
| Augmenting Drug Sensitivity | Click to Show/Hide | |||||
| Representative Experiment Reporting the Effect of This Combination | [2] | |||||
| Detail(s) |
Combination Info
click to show the detail info of this combination
|
|||||
| Molecule(s)
Regulation |
Up-regulation | Phosphorylation | ATM | Molecule Info |
Pathway MAP
|
|
| Up-regulation | Activity | CASP3 | Molecule Info |
Pathway MAP
|
||
| Up-regulation | Activity | CASP7 | Molecule Info |
Pathway MAP
|
||
| Up-regulation | Activity | CASP9 | Molecule Info |
Pathway MAP
|
||
| Up-regulation | Phosphorylation | FRP1 | Molecule Info |
Pathway MAP
|
||
| Up-regulation | Phosphorylation | TP53 | Molecule Info |
Pathway MAP
|
||
| In-vitro Model | U-251MG | CVCL_0021 | Astrocytoma | Homo sapiens | ||
| In-vivo Model | U251 cell suspension (1*109 cells) was inoculated in the armpit of 6-week-old Balb/c nude mice. | |||||
| Experimental
Result(s) |
Natural borneol enhances temozolomide-induced anticancer efficiency against human glioma by triggering mitochondrial dysfunction and reactive oxide species-mediated oxidative damage. | |||||
| Doxorubicin | Solid tumour/cancer | Click to Show/Hide the Molecular Data of This Drug | ||||
| Augmenting Drug Sensitivity | Click to Show/Hide | |||||
| Representative Experiment Reporting the Effect of This Combination | [3] | |||||
| Detail(s) |
Combination Info
click to show the detail info of this combination
|
|||||
| Molecule(s)
Regulation |
Down-regulation | Phosphorylation | AKT1 | Molecule Info |
Pathway MAP
|
|
| Down-regulation | Expression | CCNB1 | Molecule Info |
Pathway MAP
|
||
| Up-regulation | Phosphorylation | ERK1 | Molecule Info |
Pathway MAP
|
||
| Up-regulation | Phosphorylation | JNK1 | Molecule Info |
Pathway MAP
|
||
| Down-regulation | Expression | POLD1 | Molecule Info |
Pathway MAP
|
||
| Biological
Regulation |
Up-regulation | Cell cycle arrest in G2/M phase | ||||
| Up-regulation | ROS generation | |||||
| In-vitro Model | U-251MG | CVCL_0021 | Astrocytoma | Homo sapiens | ||
| U-87MG ATCC | CVCL_0022 | Glioblastoma | Homo sapiens | |||
| In-vivo Model | U251 cells (5*107) in 100 uL PBS were injected subcutaneously into the right oxter of male nude mice. | |||||
| Experimental
Result(s) |
Borneol could enhance anticancer efficiency of doxorubicin against human glioma through triggering ROS-mediated signal. | |||||
| Target and Pathway | ||||
|---|---|---|---|---|
| Target(s) | Transient receptor cation channel V3 (TRPV3) | Molecule Info | [4] | |
| KEGG Pathway | Inflammatory mediator regulation of TRP channels | Click to Show/Hide | ||
| Reactome | TRP channels | Click to Show/Hide | ||
